Skip to main content
. 2012 Oct;136(4):641–648.

Fig. 3.

Fig. 3

Virus instillation with lethal dose resulted increased mortality from 2nd day p.i. to 7th day p.i. (group II) compared with control (group I). Administration for TGF-β1 increased survival to 60% in Group III (rTGF-β1 + virus).